nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.173	0.28	CbGbCtD
Vardenafil—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.089	0.144	CbGbCtD
Vardenafil—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0864	0.14	CbGbCtD
Vardenafil—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0675	0.109	CbGbCtD
Vardenafil—CYP3A4—Betamethasone—ankylosing spondylitis	0.0579	0.0936	CbGbCtD
Vardenafil—CYP3A4—Prednisolone—ankylosing spondylitis	0.0571	0.0924	CbGbCtD
Vardenafil—CYP3A4—Prednisone—ankylosing spondylitis	0.0539	0.0872	CbGbCtD
Vardenafil—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0337	0.0544	CbGbCtD
Vardenafil—Vertigo—Triamcinolone—ankylosing spondylitis	0.000881	0.00231	CcSEcCtD
Vardenafil—Syncope—Triamcinolone—ankylosing spondylitis	0.000879	0.0023	CcSEcCtD
Vardenafil—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000879	0.0023	CcSEcCtD
Vardenafil—Syncope—Methylprednisolone—ankylosing spondylitis	0.000877	0.0023	CcSEcCtD
Vardenafil—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000874	0.00229	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00087	0.00228	CcSEcCtD
Vardenafil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000862	0.00226	CcSEcCtD
Vardenafil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00086	0.00225	CcSEcCtD
Vardenafil—Shock—Prednisolone—ankylosing spondylitis	0.000856	0.00224	CcSEcCtD
Vardenafil—Convulsion—Triamcinolone—ankylosing spondylitis	0.000849	0.00223	CcSEcCtD
Vardenafil—Tachycardia—Prednisolone—ankylosing spondylitis	0.000849	0.00222	CcSEcCtD
Vardenafil—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000848	0.00222	CcSEcCtD
Vardenafil—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000847	0.00222	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000841	0.0022	CcSEcCtD
Vardenafil—Myalgia—Triamcinolone—ankylosing spondylitis	0.000835	0.00219	CcSEcCtD
Vardenafil—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000833	0.00218	CcSEcCtD
Vardenafil—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000833	0.00218	CcSEcCtD
Vardenafil—Eye disorder—Prednisone—ankylosing spondylitis	0.000832	0.00218	CcSEcCtD
Vardenafil—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00083	0.00217	CcSEcCtD
Vardenafil—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000828	0.00217	CcSEcCtD
Vardenafil—Infestation—Methotrexate—ankylosing spondylitis	0.000828	0.00217	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000827	0.00217	CcSEcCtD
Vardenafil—Flushing—Prednisone—ankylosing spondylitis	0.000826	0.00216	CcSEcCtD
Vardenafil—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000825	0.00216	CcSEcCtD
Vardenafil—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000825	0.00216	CcSEcCtD
Vardenafil—Discomfort—Triamcinolone—ankylosing spondylitis	0.000825	0.00216	CcSEcCtD
Vardenafil—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000823	0.00216	CcSEcCtD
Vardenafil—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000816	0.00214	CcSEcCtD
Vardenafil—Angioedema—Betamethasone—ankylosing spondylitis	0.000813	0.00213	CcSEcCtD
Vardenafil—Angioedema—Dexamethasone—ankylosing spondylitis	0.000813	0.00213	CcSEcCtD
Vardenafil—Angiopathy—Prednisone—ankylosing spondylitis	0.000807	0.00212	CcSEcCtD
Vardenafil—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000805	0.00211	CcSEcCtD
Vardenafil—Immune system disorder—Prednisone—ankylosing spondylitis	0.000804	0.00211	CcSEcCtD
Vardenafil—Malaise—Betamethasone—ankylosing spondylitis	0.000802	0.0021	CcSEcCtD
Vardenafil—Malaise—Dexamethasone—ankylosing spondylitis	0.000802	0.0021	CcSEcCtD
Vardenafil—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0008	0.0021	CcSEcCtD
Vardenafil—Vertigo—Dexamethasone—ankylosing spondylitis	0.000799	0.00209	CcSEcCtD
Vardenafil—Vertigo—Betamethasone—ankylosing spondylitis	0.000799	0.00209	CcSEcCtD
Vardenafil—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000798	0.00209	CcSEcCtD
Vardenafil—Syncope—Betamethasone—ankylosing spondylitis	0.000798	0.00209	CcSEcCtD
Vardenafil—Syncope—Dexamethasone—ankylosing spondylitis	0.000798	0.00209	CcSEcCtD
Vardenafil—Infection—Triamcinolone—ankylosing spondylitis	0.000795	0.00208	CcSEcCtD
Vardenafil—Sweating—Methotrexate—ankylosing spondylitis	0.000794	0.00208	CcSEcCtD
Vardenafil—Infection—Methylprednisolone—ankylosing spondylitis	0.000793	0.00208	CcSEcCtD
Vardenafil—Haematuria—Methotrexate—ankylosing spondylitis	0.00079	0.00207	CcSEcCtD
Vardenafil—Shock—Triamcinolone—ankylosing spondylitis	0.000787	0.00206	CcSEcCtD
Vardenafil—Insomnia—Prednisolone—ankylosing spondylitis	0.000787	0.00206	CcSEcCtD
Vardenafil—Shock—Methylprednisolone—ankylosing spondylitis	0.000785	0.00206	CcSEcCtD
Vardenafil—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000783	0.00205	CcSEcCtD
Vardenafil—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000783	0.00205	CcSEcCtD
Vardenafil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000782	0.00205	CcSEcCtD
Vardenafil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000782	0.00205	CcSEcCtD
Vardenafil—Epistaxis—Methotrexate—ankylosing spondylitis	0.000781	0.00205	CcSEcCtD
Vardenafil—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000781	0.00205	CcSEcCtD
Vardenafil—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000781	0.00205	CcSEcCtD
Vardenafil—Mental disorder—Prednisone—ankylosing spondylitis	0.00078	0.00204	CcSEcCtD
Vardenafil—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000779	0.00204	CcSEcCtD
Vardenafil—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000775	0.00203	CcSEcCtD
Vardenafil—Erythema—Prednisone—ankylosing spondylitis	0.000775	0.00203	CcSEcCtD
Vardenafil—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000773	0.00203	CcSEcCtD
Vardenafil—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000772	0.00202	CcSEcCtD
Vardenafil—Convulsion—Dexamethasone—ankylosing spondylitis	0.000771	0.00202	CcSEcCtD
Vardenafil—Convulsion—Betamethasone—ankylosing spondylitis	0.000771	0.00202	CcSEcCtD
Vardenafil—Myalgia—Dexamethasone—ankylosing spondylitis	0.000757	0.00198	CcSEcCtD
Vardenafil—Myalgia—Betamethasone—ankylosing spondylitis	0.000757	0.00198	CcSEcCtD
Vardenafil—Anxiety—Betamethasone—ankylosing spondylitis	0.000755	0.00198	CcSEcCtD
Vardenafil—Anxiety—Dexamethasone—ankylosing spondylitis	0.000755	0.00198	CcSEcCtD
Vardenafil—Discomfort—Betamethasone—ankylosing spondylitis	0.000748	0.00196	CcSEcCtD
Vardenafil—Discomfort—Dexamethasone—ankylosing spondylitis	0.000748	0.00196	CcSEcCtD
Vardenafil—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000747	0.00196	CcSEcCtD
Vardenafil—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000746	0.00195	CcSEcCtD
Vardenafil—Pain—Prednisolone—ankylosing spondylitis	0.000744	0.00195	CcSEcCtD
Vardenafil—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000744	0.00195	CcSEcCtD
Vardenafil—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000738	0.00193	CcSEcCtD
Vardenafil—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000734	0.00192	CcSEcCtD
Vardenafil—Vision blurred—Prednisone—ankylosing spondylitis	0.00073	0.00191	CcSEcCtD
Vardenafil—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000729	0.00191	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000729	0.00191	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000727	0.00191	CcSEcCtD
Vardenafil—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000726	0.0019	CcSEcCtD
Vardenafil—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000726	0.0019	CcSEcCtD
Vardenafil—Insomnia—Triamcinolone—ankylosing spondylitis	0.000724	0.0019	CcSEcCtD
Vardenafil—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000722	0.00189	CcSEcCtD
Vardenafil—Infection—Betamethasone—ankylosing spondylitis	0.000721	0.00189	CcSEcCtD
Vardenafil—Infection—Dexamethasone—ankylosing spondylitis	0.000721	0.00189	CcSEcCtD
Vardenafil—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000719	0.00188	CcSEcCtD
Vardenafil—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000718	0.00188	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000717	0.00188	CcSEcCtD
Vardenafil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000717	0.00188	CcSEcCtD
Vardenafil—Visual impairment—Methotrexate—ankylosing spondylitis	0.000717	0.00188	CcSEcCtD
Vardenafil—Shock—Dexamethasone—ankylosing spondylitis	0.000714	0.00187	CcSEcCtD
Vardenafil—Shock—Betamethasone—ankylosing spondylitis	0.000714	0.00187	CcSEcCtD
Vardenafil—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000713	0.00187	CcSEcCtD
Vardenafil—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000712	0.00187	CcSEcCtD
Vardenafil—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000712	0.00187	CcSEcCtD
Vardenafil—Tachycardia—Betamethasone—ankylosing spondylitis	0.000708	0.00186	CcSEcCtD
Vardenafil—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000708	0.00186	CcSEcCtD
Vardenafil—Angioedema—Prednisone—ankylosing spondylitis	0.000708	0.00185	CcSEcCtD
Vardenafil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000704	0.00185	CcSEcCtD
Vardenafil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000703	0.00184	CcSEcCtD
Vardenafil—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000702	0.00184	CcSEcCtD
Vardenafil—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000702	0.00184	CcSEcCtD
Vardenafil—Malaise—Prednisone—ankylosing spondylitis	0.000699	0.00183	CcSEcCtD
Vardenafil—Vertigo—Prednisone—ankylosing spondylitis	0.000696	0.00182	CcSEcCtD
Vardenafil—Eye disorder—Methotrexate—ankylosing spondylitis	0.000695	0.00182	CcSEcCtD
Vardenafil—Syncope—Prednisone—ankylosing spondylitis	0.000695	0.00182	CcSEcCtD
Vardenafil—Tinnitus—Methotrexate—ankylosing spondylitis	0.000693	0.00182	CcSEcCtD
Vardenafil—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00069	0.00181	CcSEcCtD
Vardenafil—Pain—Triamcinolone—ankylosing spondylitis	0.000684	0.00179	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000681	0.00178	CcSEcCtD
Vardenafil—Hypotension—Betamethasone—ankylosing spondylitis	0.000678	0.00178	CcSEcCtD
Vardenafil—Hypotension—Dexamethasone—ankylosing spondylitis	0.000678	0.00178	CcSEcCtD
Vardenafil—Angiopathy—Methotrexate—ankylosing spondylitis	0.000675	0.00177	CcSEcCtD
Vardenafil—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000672	0.00176	CcSEcCtD
Vardenafil—Convulsion—Prednisone—ankylosing spondylitis	0.000671	0.00176	CcSEcCtD
Vardenafil—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00067	0.00176	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000661	0.00173	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000661	0.00173	CcSEcCtD
Vardenafil—Arthralgia—Prednisone—ankylosing spondylitis	0.000659	0.00173	CcSEcCtD
Vardenafil—Myalgia—Prednisone—ankylosing spondylitis	0.000659	0.00173	CcSEcCtD
Vardenafil—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000659	0.00173	CcSEcCtD
Vardenafil—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000658	0.00172	CcSEcCtD
Vardenafil—Anxiety—Prednisone—ankylosing spondylitis	0.000657	0.00172	CcSEcCtD
Vardenafil—Insomnia—Betamethasone—ankylosing spondylitis	0.000657	0.00172	CcSEcCtD
Vardenafil—Insomnia—Dexamethasone—ankylosing spondylitis	0.000657	0.00172	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000655	0.00172	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000653	0.00171	CcSEcCtD
Vardenafil—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000652	0.00171	CcSEcCtD
Vardenafil—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000652	0.00171	CcSEcCtD
Vardenafil—Discomfort—Prednisone—ankylosing spondylitis	0.000652	0.00171	CcSEcCtD
Vardenafil—Mental disorder—Methotrexate—ankylosing spondylitis	0.000651	0.00171	CcSEcCtD
Vardenafil—Erythema—Methotrexate—ankylosing spondylitis	0.000647	0.0017	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000641	0.00168	CcSEcCtD
Vardenafil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000639	0.00167	CcSEcCtD
Vardenafil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000639	0.00167	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000632	0.00166	CcSEcCtD
Vardenafil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000631	0.00165	CcSEcCtD
Vardenafil—Infection—Prednisone—ankylosing spondylitis	0.000628	0.00165	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000627	0.00164	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000627	0.00164	CcSEcCtD
Vardenafil—Back pain—Methotrexate—ankylosing spondylitis	0.000626	0.00164	CcSEcCtD
Vardenafil—Shock—Prednisone—ankylosing spondylitis	0.000622	0.00163	CcSEcCtD
Vardenafil—Pain—Betamethasone—ankylosing spondylitis	0.000621	0.00163	CcSEcCtD
Vardenafil—Pain—Dexamethasone—ankylosing spondylitis	0.000621	0.00163	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00062	0.00162	CcSEcCtD
Vardenafil—Tachycardia—Prednisone—ankylosing spondylitis	0.000617	0.00162	CcSEcCtD
Vardenafil—Skin disorder—Prednisone—ankylosing spondylitis	0.000614	0.00161	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000611	0.0016	CcSEcCtD
Vardenafil—Vision blurred—Methotrexate—ankylosing spondylitis	0.00061	0.0016	CcSEcCtD
Vardenafil—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000601	0.00157	CcSEcCtD
Vardenafil—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000598	0.00157	CcSEcCtD
Vardenafil—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000598	0.00157	CcSEcCtD
Vardenafil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000594	0.00156	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000594	0.00156	CcSEcCtD
Vardenafil—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000589	0.00154	CcSEcCtD
Vardenafil—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000588	0.00154	CcSEcCtD
Vardenafil—Malaise—Methotrexate—ankylosing spondylitis	0.000584	0.00153	CcSEcCtD
Vardenafil—Vertigo—Methotrexate—ankylosing spondylitis	0.000582	0.00152	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000576	0.00151	CcSEcCtD
Vardenafil—Dizziness—Prednisolone—ankylosing spondylitis	0.000575	0.00151	CcSEcCtD
Vardenafil—Asthenia—Triamcinolone—ankylosing spondylitis	0.000574	0.0015	CcSEcCtD
Vardenafil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000574	0.0015	CcSEcCtD
Vardenafil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000574	0.0015	CcSEcCtD
Vardenafil—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000573	0.0015	CcSEcCtD
Vardenafil—Insomnia—Prednisone—ankylosing spondylitis	0.000572	0.0015	CcSEcCtD
Vardenafil—Paraesthesia—Prednisone—ankylosing spondylitis	0.000568	0.00149	CcSEcCtD
Vardenafil—Pruritus—Triamcinolone—ankylosing spondylitis	0.000566	0.00148	CcSEcCtD
Vardenafil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000565	0.00148	CcSEcCtD
Vardenafil—Convulsion—Methotrexate—ankylosing spondylitis	0.000561	0.00147	CcSEcCtD
Vardenafil—Dyspepsia—Prednisone—ankylosing spondylitis	0.000556	0.00146	CcSEcCtD
Vardenafil—Chest pain—Methotrexate—ankylosing spondylitis	0.000551	0.00144	CcSEcCtD
Vardenafil—Myalgia—Methotrexate—ankylosing spondylitis	0.000551	0.00144	CcSEcCtD
Vardenafil—Arthralgia—Methotrexate—ankylosing spondylitis	0.000551	0.00144	CcSEcCtD
Vardenafil—Rash—Prednisolone—ankylosing spondylitis	0.000549	0.00144	CcSEcCtD
Vardenafil—Dermatitis—Prednisolone—ankylosing spondylitis	0.000548	0.00144	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000547	0.00143	CcSEcCtD
Vardenafil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000546	0.00143	CcSEcCtD
Vardenafil—Headache—Prednisolone—ankylosing spondylitis	0.000545	0.00143	CcSEcCtD
Vardenafil—Discomfort—Methotrexate—ankylosing spondylitis	0.000545	0.00143	CcSEcCtD
Vardenafil—Dizziness—Triamcinolone—ankylosing spondylitis	0.000529	0.00139	CcSEcCtD
Vardenafil—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000528	0.00138	CcSEcCtD
Vardenafil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000528	0.00138	CcSEcCtD
Vardenafil—Infection—Methotrexate—ankylosing spondylitis	0.000525	0.00138	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000521	0.00137	CcSEcCtD
Vardenafil—Asthenia—Betamethasone—ankylosing spondylitis	0.000521	0.00136	CcSEcCtD
Vardenafil—Asthenia—Dexamethasone—ankylosing spondylitis	0.000521	0.00136	CcSEcCtD
Vardenafil—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000518	0.00136	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000517	0.00135	CcSEcCtD
Vardenafil—Nausea—Prednisolone—ankylosing spondylitis	0.000517	0.00135	CcSEcCtD
Vardenafil—Pruritus—Dexamethasone—ankylosing spondylitis	0.000514	0.00135	CcSEcCtD
Vardenafil—Pruritus—Betamethasone—ankylosing spondylitis	0.000514	0.00135	CcSEcCtD
Vardenafil—Skin disorder—Methotrexate—ankylosing spondylitis	0.000513	0.00134	CcSEcCtD
Vardenafil—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000511	0.00134	CcSEcCtD
Vardenafil—Vomiting—Triamcinolone—ankylosing spondylitis	0.000509	0.00133	CcSEcCtD
Vardenafil—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000508	0.00133	CcSEcCtD
Vardenafil—Rash—Triamcinolone—ankylosing spondylitis	0.000504	0.00132	CcSEcCtD
Vardenafil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000504	0.00132	CcSEcCtD
Vardenafil—Rash—Methylprednisolone—ankylosing spondylitis	0.000503	0.00132	CcSEcCtD
Vardenafil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000503	0.00132	CcSEcCtD
Vardenafil—Headache—Triamcinolone—ankylosing spondylitis	0.000501	0.00131	CcSEcCtD
Vardenafil—Headache—Methylprednisolone—ankylosing spondylitis	0.0005	0.00131	CcSEcCtD
Vardenafil—Abdominal pain—Prednisone—ankylosing spondylitis	0.0005	0.00131	CcSEcCtD
Vardenafil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000497	0.0013	CcSEcCtD
Vardenafil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000497	0.0013	CcSEcCtD
Vardenafil—Hypotension—Methotrexate—ankylosing spondylitis	0.000494	0.00129	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000481	0.00126	CcSEcCtD
Vardenafil—Dizziness—Dexamethasone—ankylosing spondylitis	0.00048	0.00126	CcSEcCtD
Vardenafil—Dizziness—Betamethasone—ankylosing spondylitis	0.00048	0.00126	CcSEcCtD
Vardenafil—Insomnia—Methotrexate—ankylosing spondylitis	0.000478	0.00125	CcSEcCtD
Vardenafil—Nausea—Triamcinolone—ankylosing spondylitis	0.000475	0.00125	CcSEcCtD
Vardenafil—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000474	0.00124	CcSEcCtD
Vardenafil—Nausea—Methylprednisolone—ankylosing spondylitis	0.000474	0.00124	CcSEcCtD
Vardenafil—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000471	0.00123	CcSEcCtD
Vardenafil—Somnolence—Methotrexate—ankylosing spondylitis	0.00047	0.00123	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000466	0.00122	CcSEcCtD
Vardenafil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000465	0.00122	CcSEcCtD
Vardenafil—Vomiting—Betamethasone—ankylosing spondylitis	0.000462	0.00121	CcSEcCtD
Vardenafil—Vomiting—Dexamethasone—ankylosing spondylitis	0.000462	0.00121	CcSEcCtD
Vardenafil—Rash—Betamethasone—ankylosing spondylitis	0.000458	0.0012	CcSEcCtD
Vardenafil—Rash—Dexamethasone—ankylosing spondylitis	0.000458	0.0012	CcSEcCtD
Vardenafil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000457	0.0012	CcSEcCtD
Vardenafil—Dermatitis—Betamethasone—ankylosing spondylitis	0.000457	0.0012	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000456	0.0012	CcSEcCtD
Vardenafil—Headache—Betamethasone—ankylosing spondylitis	0.000455	0.00119	CcSEcCtD
Vardenafil—Headache—Dexamethasone—ankylosing spondylitis	0.000455	0.00119	CcSEcCtD
Vardenafil—Asthenia—Prednisone—ankylosing spondylitis	0.000454	0.00119	CcSEcCtD
Vardenafil—Pain—Methotrexate—ankylosing spondylitis	0.000452	0.00118	CcSEcCtD
Vardenafil—Pruritus—Prednisone—ankylosing spondylitis	0.000447	0.00117	CcSEcCtD
Vardenafil—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000435	0.00114	CcSEcCtD
Vardenafil—Diarrhoea—Prednisone—ankylosing spondylitis	0.000433	0.00113	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000432	0.00113	CcSEcCtD
Vardenafil—Nausea—Betamethasone—ankylosing spondylitis	0.000431	0.00113	CcSEcCtD
Vardenafil—Nausea—Dexamethasone—ankylosing spondylitis	0.000431	0.00113	CcSEcCtD
Vardenafil—Dizziness—Prednisone—ankylosing spondylitis	0.000418	0.0011	CcSEcCtD
Vardenafil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000418	0.00109	CcSEcCtD
Vardenafil—Vomiting—Prednisone—ankylosing spondylitis	0.000402	0.00105	CcSEcCtD
Vardenafil—Rash—Prednisone—ankylosing spondylitis	0.000399	0.00104	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—ankylosing spondylitis	0.000398	0.00104	CcSEcCtD
Vardenafil—Headache—Prednisone—ankylosing spondylitis	0.000396	0.00104	CcSEcCtD
Vardenafil—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000389	0.00102	CcSEcCtD
Vardenafil—Asthenia—Methotrexate—ankylosing spondylitis	0.000379	0.000993	CcSEcCtD
Vardenafil—Nausea—Prednisone—ankylosing spondylitis	0.000375	0.000984	CcSEcCtD
Vardenafil—Pruritus—Methotrexate—ankylosing spondylitis	0.000374	0.00098	CcSEcCtD
Vardenafil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000361	0.000947	CcSEcCtD
Vardenafil—Dizziness—Methotrexate—ankylosing spondylitis	0.000349	0.000916	CcSEcCtD
Vardenafil—Vomiting—Methotrexate—ankylosing spondylitis	0.000336	0.00088	CcSEcCtD
Vardenafil—Rash—Methotrexate—ankylosing spondylitis	0.000333	0.000873	CcSEcCtD
Vardenafil—Dermatitis—Methotrexate—ankylosing spondylitis	0.000333	0.000872	CcSEcCtD
Vardenafil—Headache—Methotrexate—ankylosing spondylitis	0.000331	0.000867	CcSEcCtD
Vardenafil—Nausea—Methotrexate—ankylosing spondylitis	0.000314	0.000822	CcSEcCtD
